(Date:11/24/2009)...rstCall/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theglo...edthatithassubmittedaMAAtotheEuropeanMedicinesAgen...enttherapyindevelopment,forthetreatmentofType1Gauc...elaglucerasealfathathasbeensubmitted,withprevious,...donaglobalsupplyshortageofthecurrentlyapprovedandm...
(Date:11/24/2009)...re/--HealthRoboticstodayannounced,thatithasformeda...ors.ThisrecentlyformedToronto-basedcompanywilloper...rket,install,andsupport,HealthRobotics,i.v.Roomoft...uctofferingsi.v.STATION(TM),i.v.SOFT(TM),andOMM(TM...ceonan"asneeded,basis"toitsstrategicpartnershipswi...
(Date:11/24/2009)...Call/--CellTherapeutics,Inc.(CTI)(NasdaqandMTA:CTI...HealthCareConference.TheconferencewillbeheldDecemb...resentonTuesday,December1at11:00a.m.EasternTimeinH...ionwillbeavailableat www.celltherapeutics.com ,and...rJaffrayHealthCareConference,NewYorkPalaceHotel,Ho...
(Date:11/23/2009)... communication, computation and more powerful ways...se quantum states as carriers of information is an...ave shown, mathematically, how to gently tease out...eping the information intact. Their work is report...s and highlighted with a Viewpoint in Physics (...
Breaking Biology Technology:Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2